As a result, the GLP-1 agonists industry remains a two-player race at the molecule level, with semaglutide and tirzepatide setting efficacy benchmarks that newer entrants must match or exceed
We are building a therapeutic strategy for the entire spectrum of liver fibrosis through DD01 and TRY-012, D&D Pharmatech CEO Lee Seul-ki said at the JP Morgan Healthcare Conference 2026 in San Francisco, Calif., on Friday (local time)
There is no FDA-approved human trial
Signals near GLP1R tracked with those stomach side effects, which fits the idea that stronger receptor activity can cut both ways
Specific Considerations Prescription Medications: If you are taking medications for blood sugar management (like metformin) or blood pressure, NMN and glutathione may interact with how these drugs are processed
Get your prescription and plan